| 11/13/2026 6:05 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/12/2026 6:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/05/2026 4:00 PM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/08/2026 7:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/06/2026 5:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/05/2026 8:39 AM | AdvisorShares Trust (1408970) Filed by Quantum Biopharma (1771885) Subject | Form SCHEDULE 13G/A | |
| 09/24/2026 7:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/17/2026 2:12 PM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/17/2026 7:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/15/2026 7:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/08/2026 11:38 AM | Quantum Biopharma (1771885) Filer | Form 6-K/A | |
Get the Latest News and Ratings for QNTM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Quantum Biopharma and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/08/2026 11:39 AM | Quantum Biopharma (1771885) Filer | Form 6-K/A | |
| 09/08/2026 11:39 AM | Quantum Biopharma (1771885) Filer | Form 6-K/A | |
| 09/01/2026 7:28 PM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/14/2026 6:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/13/2026 10:07 AM | Quantum Biopharma (1771885) Filer | Form 6-K/A | |
| 08/10/2026 6:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/08/2026 4:21 PM | AdvisorShares Trust (1408970) Filed by Quantum Biopharma (1771885) Subject | Form SCHEDULE 13G | |
| 06/02/2026 10:50 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/02/2026 6:40 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/18/2026 5:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/07/2026 6:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/22/2026 8:31 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/02/2026 7:30 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/01/2026 7:02 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/30/2026 6:50 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/27/2026 7:10 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/26/2026 7:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/23/2026 7:24 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/03/2026 8:19 AM | Malone Wealth Ventures LLC (2072045) Filed by Quantum Biopharma (1771885) Subject | Form SCHEDULE 13G/A | |
| 12/23/2025 7:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/22/2025 3:23 PM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/22/2025 2:48 PM | Quantum Biopharma (1771885) Filer | Form 424B5 | |
| 12/22/2025 6:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/11/2025 9:14 AM | Quantum Biopharma (1771885) Filer | Form 6-K/A | |
| 12/08/2025 1:39 PM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/01/2025 6:00 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/28/2025 7:25 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/26/2025 8:30 AM | Quantum Biopharma (1771885) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |